Recent Press Releases

Neuralstem Announces NSI-189 Shows Enhancement of Long-Term Potentiation In Vitro

06/21/16 - Data Contribute to Understanding NSI-189 Mechanism of Action GERMANTOWN, Md., June 21, 2016 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system the... More

Neuralstem Announces New Chairman and Further Reorganization Plans

06/13/16 - GERMANTOWN, Md., June 13, 2016 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, today announc... More

Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent

05/20/16 - GERMANTOWN, Md., May 20, 2016 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, announced a corpora... More
More

Upcoming Events


There are currently no events scheduled.
More
Print PagePrint Page
E-mail PageE-mail Page
RSS FeedsRSS Feeds
Share PageShare Page
E-mail AlertsE-mail Alerts
IR ContactsIR Contacts
Financial Tear SheetFinancial Tear Sheet